By Zhimei Wang (Director of Toxicology at WuXi AppTec)2025-12-24T09:00:55
Peptide therapeutics are emerging as a powerful class of medicines capable of targeting diseases that challenge traditional modalities. This article reveals their rising clinical impact and the key development, safety and translational challenges that must be addressed to bring them successfully to patients.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2025-05-14T14:30:00
Sponsored by Abzena
2023-03-30T09:15:30
Sponsored by Halo Labs
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2024-01-26T13:22:42
Sponsored by bit.bio
2023-11-24T12:06:45
Sponsored by Quantum-Si
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud